Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Beam’s base editing therapy for sickle cell hits goal in pivotal trial

The result represents a scientific milestone and positions Beam to submit a first-of-its-kind FDA application as soon as the end of the year.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Tuesday 10 November →